Phase 2 trials not enough info I think, so phase 3 trials will help with tga
think the first attempt was to try get nasodine through using the Covid study which tga didn’t go for and wanted more info, hence the packaging thing possibly. So if good news at the end of this month I can’t see anything stopping this stock from having a bit of price action, in the recent article we all read
https://unauthorised investment advice/health/qa-firebrick-pharma-is-just-weeks-away-from-finding-out-if-it-has-cracked-a-cure-for-the-common-cold/?amp
peter mentions at the end of it that they are ready as soon as scheduling and packaging approval from tga
